Nonrulemaking

Patient-Focused Drug Development: Selecting, Developing, or Modifying Fit-for-Purpose Clinical Outcome Assessments; Draft Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders; Availability

Documents
0
Total comments
0
all analyzed
Comment status
Closed
Last activity
In this docket

Documents

Rules, notices, and supporting material — the primary rule pinned first.

No documents mirrored for this docket yet.

© 2026 Government Context · not affiliated with any U.S. government agencyPrivacyTermsDockets